Evidence map›Paper›PMID 36651034›Full record

ArticleFEBS open bio2023

Enhancement of polyethylene glycol-cell fusion efficiency by novel application of transient pressure using a jet injector.

Chin Yang Chang, Jiayu A Tai, Yuko Sakaguchi, Tomoyuki Nishikawa, Yayoi Hirayama, Kunihiko Yamashita

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Biophysical Considerations in Cell Fusion.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Developing Advanced Chimeric Cell Therapy for Duchenne Muscular Dystrophy.International journal of molecular sciences · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Chin Yang ChangDepartment of Device Application for Molecular Therapeutics, Graduate School of Medicine, Osaka University, Japan.ORCID 0000-0002-7370-6026
Jiayu A TaiDepartment of Device Application for Molecular Therapeutics, Graduate School of Medicine, Osaka University, Japan.
Yuko SakaguchiMedical Device Division, Industry Business Unit, Safety Strategic Business Unit, Daicel Co., Osaka, Japan.
Tomoyuki NishikawaDepartment of Device Application for Molecular Therapeutics, Graduate School of Medicine, Osaka University, Japan.
Yayoi HirayamaMedical Device Division, Industry Business Unit, Safety Strategic Business Unit, Daicel Co., Osaka, Japan.
Kunihiko YamashitaDepartment of Device Application for Molecular Therapeutics, Graduate School of Medicine, Osaka University, Japan.
Daicel (Japan) · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-cell fusion involves the fusion of somatic cells into a single hybrid cell. It is not only a physiological process but also an important cell engineering technology which can be applied to various fields, such as regenerative medicine, antibody engineering, genetic engineering, and cancer therapy. There are three major methods of cell fusion: electrical cell fusion, polyethylene glycol (PEG) cell fusion, and virus-mediated cell fusion. Although PEG cell fusion is the most economical approach and does not require expensive instrumentation, it has a poor fusion rate and induces a high rate of cell cytotoxicity. To improve the fusion rate of the PEG method, we combined it with the pyro-drive jet injector (PJI). PJI provides instant pressure instead of cell agitation to increase the probability of cell-to-cell contact and shorten the distance between cells in the process of cell fusion. Here, we report that this improved fusion method not only decreased cell cytotoxicity during the fusion process, but also increased fusion rate compared with the conventional PEG method. Furthermore, we tested the functionality of cells fused using the PJI-PEG method and found them to be comparable to those fused using the conventional PEG method in terms of their application for dendritic cell (DC)-tumor cell fusion vaccine production; in addition, the PJI-PEG method demonstrated excellent performance in hybridoma cell preparation. Taken together, our data indicate that this method improves cell fusion efficiency as compared to the PEG method and thus has the potential for use in various applications that require cell fusion technology.

Indexed as

Genetic EngineeringPolyethylene GlycolsCell FusionPolyethylene Glycolsantibody engineeringcell fusionjet injectorPEGpolyethylene glycolvaccine

Identifiers

PMID36651034
PMCPMC9989930
OpenAlexW4317358591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.